Prescription Required 
Formulation : 
Description
Indications
Dalfampridine is indicated for the enhancement of walking in individuals afflicted with multiple sclerosis (MS), a neurological disorder characterized by impaired nerve function. Dalfampridine belongs to the class of pharmaceuticals known as potassium channel blockers, which exert their therapeutic effect by fortifying the neural transmission signals originating from the brain, specifically targeting nerves that have incurred damage due to MS.
Uses and Dosage
Dalfampridine is administered orally in the form of extended-release tablets. It is typically taken twice daily, either with or without food. Establish a regimen in which doses are spaced approximately 12 hours apart, adhering to consistent administration times each day.
Take dalfampridine exactly as prescribed, refraining from adjusting the dosage or frequency without medical guidance.
The tablets should be swallowed whole and should not be split, chewed, dissolved, or crushed.
Dalfampridine is not available through conventional pharmacies; it can only be obtained via mail from a specialized pharmacy. If you have any inquiries regarding the procurement of your medication, consult your doctor for further clarification.
The potential benefits of dalfampridine in improving walking ability can only be sustained through consistent usage. It may take up to six weeks or longer before experiencing the full therapeutic effects of dalfampridine. Continue taking the medication as prescribed, even if you feel well. Discontinuing dalfampridine should only be done in consultation with your doctor and should not be undertaken independently.
Side Effects
Some side effects may occur that usually do not need medical attention:
- difficulty falling asleep or staying asleep
- dizziness
- headache
- nausea
- heartburn
- constipation
- weakness
- back pain
- difficulty with balance
- worsening of multiple sclerosis symptoms
- burning, tingling, or itching of the skin
- pain or irritation in the nose or throat
Inform your healthcare provider immediately if you experience any serious side effects:
- seizures
- painful, difficult, or frequent urination
- fever or chills
- pain in the back, side, or stomach
Caution
Prior to initiating dalfampridine treatment, inform your doctor or pharmacist about any known allergies you may have, including allergies to dalfampridine or other substances. This product may contain inactive components that can trigger allergic reactions or other adverse effects.
Before using this medication, disclose your medical history to your doctor or pharmacist, particularly if you have a history of kidney disease or seizures.
This drug may induce dizziness. Consumption of alcohol or marijuana can intensify this effect. Refrain from operating machinery, driving, or engaging in activities requiring alertness until you can safely do so.
During pregnancy, dalfampridine should only be utilized when the potential benefits clearly outweigh the risks. Have a discussion with your doctor regarding the potential risks and benefits associated with the use of this medication during pregnancy.
The passage of this medication into breast milk is currently unknown. Prior to breastfeeding, consult with your doctor regarding the potential risks and benefits involved.
Form and Strength
Ampyra is available in the following forms and strengths:
-
Ampyra extended-release tablet:
- 10mg
-
dalfampridine extended-release tablet:
- 10mg
FAQ
How long does it take for Ampyra to start working?
Some patients experienced improvement in their walking ability within a couple of weeks. Others noticed improvement up to 6 weeks after starting Ampyra.
Is Ampyra an immunosuppressant?
No, Ampyra isn’t an immunosuppressant that weakens your immune system. Ampyra doesn’t affect the immune system. It’s considered symptomatic treatment since it can help people with MS walk better.
